Nuclera, a biotechnology company enabling rapid protein expression and purification screening through its benchtop protein platform, has appointed William J Kullback as a non-executive director.
TechnologyChristie & Co: Chris Lekkas

Business property advisor Christie & Co has appointed Chris Lekkas as an associate director within its dental team, based in London.
Lekkas is tasked with spearheading key dental transactions across London and the South of England and building new business.
With more than 11 years’ experience in the UK dental market, Lekkas has led and completed numerous transactions in his previous role as an M&A manager at three dental consolidators. He played a key role in growing Dentex from a start-up into a large-scale dental group, culminating in its sale and merger with Portman Dental Care last year.
Lekkas said: “For nearly 12 years, I have been dedicated to advising dental practice owners, appraising their businesses, and successfully expanding three dental groups through a variety of acquisition strategies. My experience encompasses the entire sector, including NHS, private, and specialist practices, among others.
“What I find most fulfilling about my work is the opportunity to help practice owners reach their professional, financial, and personal goals with each transaction. I am excited to continue this journey in my new role at Christie & Co, where I look forward to working with a team renowned for providing industry-leading advice to their clients.”
Joel Mannix, head of Dental at Christie & Co, commented: “With his extensive experience in the dental industry, Chris is poised to elevate our already well-established presence in London and the Southeast to new heights. His impressive track record in managing high-profile transactions, combined with his deep understanding of the UK dental market, makes him an invaluable addition to Christie & Co and our clients. We are confident that his experience will be instrumental in driving our continued growth and success within the sector.”
Latest Executive Moves
Cambridge Cognition, which provides cognitive assessment software for clinical trials, academic research and healthcare, has appointed Jonathan Kempster as an independent non-executive director.
TechnologyStax has appointed Adam Thorpe as a managing director in its London office to lead the firm’s EMEA healthcare vertical.